Physician profile
Dean Porter
NPI 1699725218
$1,067.37
in general payments reported to CMS, 2019-2025
13 companies · $97.72 in 2025
The $97.72 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $279 · 2021: $142 · 2022: $59.31 · 2023: $208 · 2024: $87.05 · 2025: $97.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $309.14 | 2019-2021 | |
| Abbvie INC. | $236.25 | 2023-2025 | |
| Alcon Vision LLC | $144.87 | 2020-2023 | Argos |
| Novartis Pharmaceuticals Corporation | $93.90 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.47 | 2019-2021 | |
| Akorn Operating Company LLC | $46.06 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $39.51 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $34.13 | 2025 | Xdemvy |
| Dompe US, INC. | $25.17 | 2023 | Oxervate |
| Biotissue Holdings INC. | $24.70 | 2024 | |
| Aerie Pharmaceuticals, INC. | $18.58 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.00 | 2025 | |
| Oyster Point Pharma, INC. | $16.59 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.